Group
A system of companies founded on research and development.
In 2016, the Sacco System business network formed by Caglificio Clerici spa, Sacco srl, Centro Sperimentale del Latte srl and Kemikalia SA. (now Sacco System Nordic) came to life and in 2021 became Sacco System Holding.
The Verga family, at the helm of the company for five generations, wants to look ahead, pushing further on group synergies so as to achieve structured and lasting growth at the international level in the coming years.
With this new corporate structure, it intends to face the challenge of development at the international level, placing itself on the market with even greater value not only at the economic and equity level but also in terms of brand and therefore business, thanks to a mentality that is increasingly open to innovation and growth.
Sacco System is a “microbial innovator”: we research, study, and develop microorganisms to make the lives of humans, animals, and plants better.
Lactic ferments, probiotics, enzymes and many other ingredients to promote well-being.
Sacco System’s People will continue to be instrumental in positioning itself profitably in the biotechnology market with an increasingly strong and recognized brand.

The history of Caglificio Clerici is primarily a family story, over 150 years of passion for research and technological innovation Made in Italy.
Founded in 1872 in Cadorago, Caglificio Clerici specializes in the production of rennet, coagulants, and other enzymes for the dairy industry.
Today, the company is dedicatedly led by the fourth and fifth generations of descendants of the founder Martino Clerici and is part of the Sacco System group.
History

Since 1934, Sacco has been an international reference point in the biotech sector, providing advanced solutions for research, scale-up, production, and packaging of selected microbial cultures from a collection of over 6,500 strains. Sacco cultures are used in various fields, from the food industry to plant and animal welfare.
The Labware division offers a wide range of products for laboratories, businesses, and research centers.
The Research & Development team, the heart of the company, is dedicated to the study and development of microbial cultures, with the goal of exploring and discovering new applications.
History

The history of CSL – Centro Sperimentale del Latte began in 1948, when founder Leo Vesely started studying bacteria for human health and infant nutrition.
In addition to the development of probiotic solutions based on proprietary strains, CSL’s current offering includes the formulation of blends designed to meet the specific needs of customers and markets, as well as technological development services for probiotics, postbiotics, next-gen, and LBP’s (Live Biotherapeutics).
The vast collection of probiotic microbial strains, supported by clinical studies, is applied in nutraceutical and pharmaceutical solutions for gastrointestinal, oral, and skin health, as well as for women’s and children’s health, the immune system, in addition to supporting the treatment of allergies and enhancing sports performance.
History

Based in Tokyo, Sacco System Japan offers a wide range of innovative products and technical services for the promotion and sale of lactic ferments, cheese coagulants, and probiotics.

Based in Skurup (Sweden), Sacco System Nordic produces basic organic chemical products.
History

In 2024, Sacco System Australia was established in Brisbane. Our laboratories support companies in the development, validation of processes, and commercial production of probiotics, postbiotics, next-generation bacteria (from obligate aerobic bacteria to strict anaerobic strains), and live biotherapeutics for the dietary supplement, biotechnology, and pharmaceutical sectors.

Based in Echirolles, Sacco System France produces a variety of culture and enzyme solutions for dairy, meat, fish, other food products, and probiotics for the French market.

Based in Singapore, CSL Apac is dedicated to the market development of probiotics, postbiotics and next gen (newly identified probiotics through comparative genomics technologies) for the nutraceutical and pharmaceutical sectors in the Asia-Pacific region.
Our services:
• Support for commercialization
• High-quality and well-documented probiotics
• Support for clinical trials
• Regulatory support
• Technical support

Headquartered in Franksville, Wisconsin, CSL USA produces and markets probiotics for nutritional and pharmaceutical applications in the U.S. market. It also provides fermentation services for Sacco System partners who own proprietary strains.

Synbiotec Laboratories, founded in 2005 as a spin-off of UNICAM – University of Camerino, is a leading company in probiotic research and development for applications in functional foods and nutraceuticals. Since 2021, it has been part of the Sacco System group. Thanks to its expertise in developing and applying live microorganisms, the company has implemented a series of research programs aimed at better understanding the properties, mechanisms, and effects of its probiotic line on human and animal health.
With over 30 years of research activity, Synbiotec can provide high-quality probiotics with documented health benefits.